Hopital Saint Louis

Paris, Île-de-France Region 75475

1 studies enrolling now · 3 studies all time

What they study most

CTCL, Diffuse Large B-cell Lymphoma, Hematopoietic Stem Cells

Studies at this site

• A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL — Recruiting now
• Vedolizumab in the Prophylaxis of Intestinal Acute Graft Versus Host Disease (aGVHD) in Participants Undergoing Allogeneic Hematopoietic Stem Cell (Allo-HSCT) Transplantation — Completed
• TAK-659 in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) — Stopped early